Status:

RECRUITING

Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Burns Surgery

Eligibility:

All Genders

18-99 years

Phase:

PHASE3

Brief Summary

The indication of antibiotic prophylaxis in burn patients remains highly controversial and hasn't reached a consensus. The objective of antibiotic prophylaxis would be to reduce the risk of post-opera...

Detailed Description

The intensive care unit investigator will verify the inclusion and non-inclusion criteria. The following parameters will be collected at ICU/burn centers: Hemodynamic parameters; sepsis organ failure...

Eligibility Criteria

Inclusion

  • Patient over 18 years and less than 80 years old
  • Burned patients requiring at least one excision-graft surgery
  • Burn TBSA% between 5% and 40%
  • Signed informed consent or inclusion under the emergency provisions of the law (article L1122-1-2 of the CSP)

Exclusion

  • Proven severe allergy to cephalosporin or piperacilline-tazobactam or any other antibacterial agent of the penicillin class
  • History of severe allergic reaction to any other beta-lactam (eg cephalosporins, monobactams or carbapenems).
  • Patient on antibiotic therapy at the time of surgery
  • Pregnant or breast-feeding patient
  • Patient not covered by the social security
  • Patient transferred from another burn Unit
  • Patient participant in investigational competitive medicinal product study on the primary endpoint
  • Patient with local or systemic signs of infection requiring systemic antimicrobial therapy
  • Patient under guardianship
  • Patient under curatorship
  • known colonization of the burned area to be excised with tazocillin-resistant germ.
  • obese patient with BMI \> 50 kg/m²

Key Trial Info

Start Date :

October 11 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 9 2026

Estimated Enrollment :

506 Patients enrolled

Trial Details

Trial ID

NCT04292054

Start Date

October 11 2020

End Date

July 9 2026

Last Update

November 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Saint Louis Hospital

Paris, France, 75010